BBACN composition for antibacterial and anti-inflammatory applications received South Korea patent approval.
https://blueblood.com.tw/wp-content/uploads/2024/09/dna-genetic-biotechnology-science-with-scientist-rsquo-s-hands-disruptive-technology-remix.jpg8001200agent30/wp-content/uploads/2025/03/logo-color.pngagent302013-05-01 12:00:492025-08-28 10:03:58BBACN composition for antibacterial and anti-inflammatory applications received South Korea patent approval.
